13:57 JST, October 28, 2022
SARAJEVO (Reuters) — Serbian scientists have named a new species of beetle after tennis great Novak Djokovic due to its speed, strength, flexibility, durability and ability to survive in a difficult environment, Serbian media reported on Oct. 7.
The insect, which belongs to the Duvalius genus of ground beetles that is present in Europe, was discovered several years ago in an underground pit in western Serbia.
It is named Duvalius Dokovici, the Tanjug news agency quoted researcher Nikola Vesovic as saying.
Vesovic said that the new species was a specialized underground Coleoptera beetle, a predator that had lost its eyes living deep underground.
“I proposed to name the new species after Djokovic,” Vesovic was quoted as saying. “He is the man who did much for this country. We feel urged to pay him back in the way we can.”
The 35-year-old Djokovic, who has won 21 Grand Slam trophies, won the Tel Aviv Open to clinch his third title this season, after winning a seventh Wimbledon crown in July.
He was playing on Oct. 7 against Karen Khachanov in the quarter finals of the Astana Open, which also featured fourth-ranked Russian Daniil Medvedev who was also in the last eight. Top seed Carlos Alcaraz was knocked out in the first round.
Top Articles in Science & Nature
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
Parents in Japan to Get Instagram Notifications When Teens Repeatedly Search for Suicide Content
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
-
Japan to Ban Use of Power Banks on Airplanes
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

